Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ionic liquid method for cyclopentanone production offering high selectivity and catalyst recycling for fine chemical supply chains.
Patent CN111793037B reveals advanced crystallization for 3,6-difluoropyrazine-2-carbonitrile. Ensures supply chain reliability and cost reduction.
Patent CN102786498A details a novel Repaglinide synthesis using CDI coupling and optimized deprotection, offering significant cost reduction and scalability for API manufacturing.
Novel patent CN105001114B offers high-purity Iopromide preparation. Reduces by-products and simplifies supply chain for contrast agent manufacturing.
Patent CN102336703B details a green Bi2O3-catalyzed oxidation and HATU coupling route for Roflumilast, offering superior yield and supply chain reliability for global pharma buyers.
Patent CN103012256B details a safer sodium amide catalyzed route for roflumilast. This method ensures high purity and yield while reducing hygroscopic risks for supply chains.
Advanced synthesis of liver-targeting ligand via nucleophilic substitution. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN113403350A reveals a novel enzymatic route for high-purity acetylhydroxyproline, offering significant cost reduction and scalable manufacturing for the cosmetic industry.
Patent CN114394913B introduces a metal-free heteropolyacid catalyzed synthesis of oxime ethers. This method offers significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN111116510B discloses a mild cobalt-catalyzed route for dihydrobenzothiazole derivatives, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106966990A reveals metal-free synthesis. High yield, mild conditions. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN110885357B details nanofiltration purification for glutamine dipeptide ensuring high purity and reduced energy consumption for reliable supply chains.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108191785A reveals metal-free synthesis for 4,5-dihydroisoxazoles. Offers high yield and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN101979391A details a novel mixed catalyst method for Tiotropium Bromide, ensuring EP-compliant isomer levels and robust supply chain reliability for global pharmaceutical manufacturers.
Patent CN106967155B details mild liquid phase oxytocin synthesis ensuring high purity and potency offering significant supply chain cost reduction advantages for pharmaceutical manufacturers.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Novel biomass-derived route for 4-methylbenzaldehyde using ionic liquids and graphite oxide catalysts ensures cost reduction and supply chain reliability for global buyers.
Patent CN107557412A details immobilized enzyme catalysis for NADPH. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.